![Bitcoin price today: flat at $61k amid Mt Gox, inflation jitters](https://i-invdn-com.investing.com/news/moved_small-LYNXMPEI5D0A7_L.jpg)
Please try another search
ABION Inc. operates as a pharmaceutical biotech Company in South Korea and internationally. The company develops anticancer therapeutic drugs, such as ABN401, a tyrosine kinase inhibitor that is in Phase II clinical trials for treating non-small cell lung cancer, as well as in Phase I clinical trial for breast cancer; ABN501, a human monoclonal antibody that targets claudin 3 for treating solid cancers; ABN201, an antibody cytokine fusion protein to treat solid cancers; and ABN101, a dry powder inhaler as a prophylactic treatment for various respiratory viruses. It is also developing ABN701 for SEBI infectious diseases; and ABN 901, ABN 902, and ABN 903 for infectious diseases related to biological disasters. Abion Inc. was founded in 2007 and is based in Seoul, South Korea.
Name | Age | Since | Title |
---|---|---|---|
Young-Gi Shin | 53 | - | CEO, President & Inside Director |
Kim Ji-Hoon | 54 | 2018 | Inside Director |
Kang Jin-Woo | 49 | 2017 | Inside Director |
Kim Jung-Min | 58 | 2017 | Inside Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review